Results 171 to 180 of about 113,483 (233)

A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal Impairment, and Food. [PDF]

Pharmaceutics
Nemitz N, Elias M, König M.
europepmc   +1 more source

Relationship between the shape of the tibial plateau and femorotibial contact mechanics after meniscectomy in the canine stifle. [PDF]

Front Vet Sci
Pozzi A, Natsios P, Kim SE, Choate CJ, Conrad BP.   +4 more
europepmc   +1 more source

Advancements in functional smart and wearable textiles for sportswear applications. [PDF]

RSC Adv
Islam MT, Hosen MI, Islam T, Al Mamun MA, Islam T.   +4 more
europepmc   +1 more source

Dla kogo Nike?

, 2002
Bereza, Henryk, Borkowska, Grażyna, Drzewucki, Janusz, Fiut, Aleksander, Gondowicz, Jan, Illg, Jerzy, Kłoczowski, Piotr, Krynicki, Ryszard, Łubieński, Tomasz, Maliszewski, Karol, Myszkowski, Krzysztof, Nowacki, Dariusz, Nyczek, Tadeusz, Orski, Mieczysław, Stala, Marian, Szczuka, Kazimiera, Śliwiński, Potr, Toruńczyk, Barbara, Wyka, Marta   +18 more
openaire   +1 more source

Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. [PDF]

ACS Pharmacol Transl Sci
Rafehi M, Tägl F, Arlt NS, Neif M, Stefan K, Ismail Al-Khalil W, Busch H, Möller M, König J, Namasivayam V, Stefan SM.   +10 more
europepmc   +1 more source

Nike Inc.

, 2009
openaire   +1 more source

Self-Determined Health App Evaluation Questionnaire Development: Mixed Methods Study.

JMIR Hum Factors
Rzepka A, Edegger K, Welte S, Bertel D, Mandl A, Schreier G.   +5 more
europepmc   +1 more source

adidas vs. nike

, 2020
openaire   +1 more source

Dla kogo Nike?

, 2004
Markowski, Michał, Wyka, Marta
openaire   +1 more source

Nagroda Nike 2001

, 2001
Fiut, Aleksander, Nowakowski, Andrzej, Nycz, Ryszard, Stala, Marian, Wyka, Marta   +4 more
openaire   +1 more source